TGF-β controls alveolar type 1 epithelial cell plasticity and alveolar matrisome gene transcription in mice.
Humans
Mice
Animals
Infant, Newborn
Receptor, Transforming Growth Factor-beta Type II
/ genetics
Pulmonary Alveoli
/ metabolism
Transforming Growth Factor beta
/ genetics
Mechanotransduction, Cellular
Proteomics
Alveolar Epithelial Cells
Lung
/ pathology
Cell Differentiation
Extracellular Matrix
/ metabolism
Bronchopulmonary Dysplasia
/ pathology
Transcription, Genetic
Extracellular matrix
Integrins
Pulmonology
Respiration
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
received:
08
05
2023
accepted:
05
01
2024
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
Premature birth disrupts normal lung development and places infants at risk for bronchopulmonary dysplasia (BPD), a disease disrupting lung health throughout the life of an individual and that is increasing in incidence. The TGF-β superfamily has been implicated in BPD pathogenesis, however, what cell lineage it impacts remains unclear. We show that TGFbr2 is critical for alveolar epithelial (AT1) cell fate maintenance and function. Loss of TGFbr2 in AT1 cells during late lung development leads to AT1-AT2 cell reprogramming and altered pulmonary architecture, which persists into adulthood. Restriction of fetal lung stretch and associated AT1 cell spreading through a model of oligohydramnios enhances AT1-AT2 reprogramming. Transcriptomic and proteomic analyses reveal the necessity of TGFbr2 expression in AT1 cells for extracellular matrix production. Moreover, TGF-β signaling regulates integrin transcription to alter AT1 cell morphology, which further impacts ECM expression through changes in mechanotransduction. These data reveal the cell intrinsic necessity of TGF-β signaling in maintaining AT1 cell fate and reveal this cell lineage as a major orchestrator of the alveolar matrisome.
Identifiants
pubmed: 38488000
pii: 172095
doi: 10.1172/JCI172095
doi:
pii:
Substances chimiques
Receptor, Transforming Growth Factor-beta Type II
EC 2.7.11.30
Transforming Growth Factor beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM